Incidence, coronary risk profile and angiographic characteristics of prediabetic and diabetic patients in a population with ischemic heart disease

Canadian Journal of Cardiology

Volumn 19, Issue 10, 2003, Pages 1155-1160

  Solymoss, B Charles ^a   Bourassa, Martial G ^a   Campeau, Lucien ^a   Lespérance, Jacques ^a   Marcil, Michel ^b   Varga, Susan ^c  

^a MONTREAL HEART INSTITUTE   (Canada)

^b ROYAL VICTORIA HOSPITAL   (Canada)

^c MONTREAL GENERAL HOSPITAL   (Canada)

Author keywords

Atherosclerosis; Coronary disease; Diabetes; Mellitus; Syndrome X

Indexed keywords

ANTICOAGULANT AGENT; ANTILIPEMIC AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; THIAZIDE DIURETIC AGENT; TRIACYLGLYCEROL;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; BLOOD PRESSURE; CANADA; CARDIOVASCULAR DISEASE; COMPARATIVE STUDY; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; CORONARY RISK; DATA BASE; DIABETES MELLITUS; DIET RESTRICTION; DYSLIPIDEMIA; FEMALE; GLUCOSE BLOOD LEVEL; HOMEOSTASIS; HUMAN; HYPERLIPIDEMIA; INCIDENCE; INSULIN RESISTANCE; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MODEL; OBESITY; DIABETIC ANGIOPATHY; HEART MUSCLE ISCHEMIA; IMPAIRED GLUCOSE TOLERANCE; MIDDLE AGED; RISK ASSESSMENT;

AGED; CORONARY ANGIOGRAPHY; CORONARY ARTERIOSCLEROSIS; DIABETIC ANGIOPATHIES; FEMALE; HOMEOSTASIS; HUMANS; INCIDENCE; INSULIN RESISTANCE; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; PREDIABETIC STATE; QUEBEC; RISK ASSESSMENT;

EID: 0142024785     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Kazi AA, Blonde L. Classification of diabetes mellitus. Clin Lab Med 2001;21:1-13.
2. Haffner SM. Impaired glucose tolerance, insulin resistance and cardiovascular disease. Diabet Med 1997;14:S12-8.
3. McPhillips JB, Barrett-Connor E, Wingard DL. Cardiovascular disease risk factors prior to diagnosis of impaired glucose tolerance and non-insulin dependent diabetes mellitus in a community of older adults. Am J Epidemiol 1990;131:443-53.
4. Medalie JH, Papier CM, Goldbourt U, Herman JB. Major factors in the development of diabetes mellitus in 10,000 men. Arch Intern Med 1975;135:811-7.
5. Haffner SM, Stern MP, Hazuda HP, Mitchell BD, Patterson JK. Cardiovascular risk factors in confirmed prediabetic individuals. Does the clock for coronary heart disease start ticking before the onset of clinical diabetes? JAMA 1990;263:2893-8.
6. Mykkanen L, Kuusisto J, Pyorala K, Laakso M. Cardiovascular disease risk factors as predictors of type II (non-insulin-dependent) diabetes mellitus in elderly subjects. Diabetologia 1993;36:553-9.
7. American Diabetes Association. Report of the Expert Committee on the Diagnosis and classification of Diabetes Mellitus. Diabetes Care 1997;20:1183-97.
8. Diabetes in Canada. National statistics and opportunities for improved surveillance, prevention, and control. Health Canada 1999:3-14.
9. Kenny SJ, Aubert RE, Geiss LS. Prevalence and incidence of non-insulin-dependent diabetes. In: Diabetes in America. NIH 1995:47-67.
10. The Bypass Angioplasty Revascularisation Investigation (BARI) Investigators. Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease. N Engl J Med 1996;335:217-25.
11. Kip KE, Faxon DP, Detre KM, Yeh W, Kelsey SF, Currier JW, Coronary angioplasty in diabetic patients. The National Heart, Lung, and Blood Institute Percutaneous Transluminal Coronary Angioplasty Registry. Circulation 1996;94:1818-25.
12. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-9.
13. Sinha R, Fisch G, Teague B, et al. Prevalence of impaired glucose tolerance among children and adolescents with marked obesity. N Engl J Med 2002;346:802-10.
14. Moise A, Clement B, Saltiel J. Clinical and angiographic correlates and prognostic significance of the coronary extent score. Am J Cardiol 1988;61:1255-9.
15. Troisi RJ, Cowiee CC, Harris MI. Diurnal variation in fasting plasma glucose: Implications for diagnosis of diabetes in patients examined in the afternoon. JAMA 2000;284:3157-9.
16. Dobiasova M, Frohlich J. The plasma parameter log (TG/HDL-C) as an atherogenic index correlation with lipoprotein particle size and esterification rate in aloB-lipoprotein depleted plasma (FER(HDL)). Clin Biochem 2001;34:583-8.
17. Reaven GM, Chen YD, Jeppesen J, Maheux P, Krauss RM. Insulin resistance and hyperinsulinimia in individuals with small, dense low density lipoprotein particles. J Clin Invest 1993;92:141-6.
18. Lamarche B, Lemieux I, Despres JP. The small dense LDL phenotype and the risk of coronary heart disease: Epidemiology, pathophysiology and therapeutic aspects. Diabetes Metab 1999;25:199-211.
19. Sniderman AD, Scantleburty T, Cianflone K. Hypertriglyceridemic HyperapoB: The unappreciated atherogenic dyslipidemia in type 2 diabetes mellitus. Ann Int Med 2001;135:447-59.
20. Haffner SM. Technical review: Management of dyslipidemia in adults with diabetes. Diabetes Care 1998;21:160-78.
21. Stamler J, Vacaro O, Neaton JD, Wentworth D. Diabetes, other risk factors and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 1993;16:434-44.
22. Tominaga M, Eguchi H, Manaka H, et al. Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose. The Funagata Diabetes Study. Diabetes Care 1999;22:920-40.
23. Hanefeld M, Temelkova-Kurktschiev T, Schaper F, Henkel E, Sigert G, Koehler C. Impaired fasting glucose is not a risk factor for atherosclerosis. Diabet Med 1999;16:212-8.
24. Bonora E, Kiechl S, Willeit J, et al. Plasma glucose within the normal range is not associated with carotid atherosclerosis: Prospective results in subjects with normal glucose tolerance from the Bruneck Study. Diabetes Care 1999;22:1339-46.
25. Folsom AR, Szklo M, Stevens J, Liao F, Smith R, Eckfeldt JH. A prospective study of coronary heart disease in relation to fasting insulin, glucose and diabetes. The atherosclerosis risk in community (ARIC) Study. Diabetes Care 1997;20:935-42.
26. Alexander CM, Landsman PB, Teutsch SM. Diabetes mellitus, impaired fasting glucose, atherosclerotic risk factors, and prevalence of coronary heart disease. Am J Cardiol 2000;86:897-902.
27. Haffner SM, Alexander CM, Cook TJ, et al. Reduced coronary events in simvastatin-treated patients with coronary heart disease and diabetes or impaired fasting glucose levels: Subgroup analyses in the Scandinavian Simvastatin Survival Study. Arch Intern Med 1999;159:2661-7.
28. Ledru F, Ducimetiere P, Battaglia S, et al. New diagnostic criteria for diabetes and coronary artery disease: Insights from an angiographic study. J Am Coll Cardiol 2001;37:1543-50.
29. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults: Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 2001;285:2486-97.